Screened 2026-09-10 · the tape above runs as of 09:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its accumulation label.
Spotify Technology SA holds its Accumulation at $521.73. Consolidating, no directional conviction, held for 9 days.
As held on the ledger · 2026-09-10
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 9 days
Price at the screen
$521.73
Valuation
28.19 trailing · 28.92 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.59
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
13.03%
Below 33%
Interest-bearing debt is just 13.0% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
28.03%
Below 33%
Cash held in interest-bearing accounts and securities is 28.0% of assets, under the one-third limit.
Pass
Receivables
38.59%
Below 49%
Money owed to the company is 38.6% of assets, under the 49% limit.
Pass
Revenue purity
1.43%
Below 5%
Only 1.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-10 screen. The gold marker is the market price at the same screen. The price runs 9.4% above the base estimate.
Third-party analyst targets: 39 covering, consensus Buy. The average target sits +20% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-10 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Spotify offers little margin of safety
Millions tap play on a commute and never think about the pipes behind the music. Spotify sits just 4 percent below our fair value of 499 dollars at the current price, with revenue rising only 8 percent and a narrow moat protecting the business.
High returns on equity of 38 percent and a 15 percent profit margin look solid on paper, yet the forward multiple of 26 times earnings prices in steady execution. The ethical screen clears, but an opportunity rating of none reflects that the shares are not cheap enough to stand out.
Analyst targets sit higher at 601 dollars, yet any slip in subscriber adds or rising content costs would compress those returns quickly. Currency moves and competition from bigger tech players remain real drags. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Sweden and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
SPOT trades on the NYSE (the company is based in Sweden). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-29Markup$537.84+11.4%Entry 12
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 11.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (38 analysts) rates it buy, with a mean price target of $599.
2026-07-28Markup$482.66+0.0%Entry 11
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (38 analysts) rates it buy, with a mean price target of $599. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-27Markup$482.66+0.0%Entry 10
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (38 analysts) rates it buy, with a mean price target of $599. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-26Markup$482.66+0.0%Entry 9
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (38 analysts) rates it buy, with a mean price target of $599. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-25Markup$482.66+0.9%Entry 8
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (38 analysts) rates it buy, with a mean price target of $599. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-24Markup$478.14+0.0%Entry 7
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (38 analysts) rates it buy, with a mean price target of $599. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-23Markup$478.14+0.0%Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (38 analysts) rates it buy, with a mean price target of $599. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-22Markup$478.14+0.0%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (38 analysts) rates it buy, with a mean price target of $599. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-21Markup$478.14-0.8%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (38 analysts) rates it buy, with a mean price target of $599. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-18Markup$482.00+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 27%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (38 analysts) rates it buy, with a mean price target of $599.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
